Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kittner

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
International Journal of Colorectal Disease|April 30, 2015
Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decadesJoern Fischer, Fischer Joern, Gunter Hellmich, et al.
Deutsches Arzteblatt International|January 29, 2026
Pretreatment MRI Versus Postoperative Pathology in Locoregional Staging of Rectal Cancer: A Germany-Wide Multicenter Re-Evaluation Study in Non-Pretreated Patients Based on the OCUM StudySigmar Stelzner, Matthias Kuhn, Reinhard Ruppert, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 26, 2010
Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumineAntonella Filippone, Anthony Blakeborough, Josy Breuer, et al.
European Journal of Radiology|April 7, 2007
Efficacy and safety of gadodiamide (Gd-DTPA-BMA) in renal 3D-magnetic resonance angiography (MRA): a phase II studyThomas Kittner, Jens Rudolf, Joan Falco Fages, et al.
European Radiology|July 9, 2008
Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trialBernd Tombach, Klaus Bohndorf, Wolfgang Brodtrager, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
International Journal of Colorectal Disease|April 30, 2015
Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decadesJoern Fischer, Fischer Joern, Gunter Hellmich, et al.
Deutsches Arzteblatt International|January 29, 2026
Pretreatment MRI Versus Postoperative Pathology in Locoregional Staging of Rectal Cancer: A Germany-Wide Multicenter Re-Evaluation Study in Non-Pretreated Patients Based on the OCUM StudySigmar Stelzner, Matthias Kuhn, Reinhard Ruppert, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 26, 2010
Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumineAntonella Filippone, Anthony Blakeborough, Josy Breuer, et al.
European Journal of Radiology|April 7, 2007
Efficacy and safety of gadodiamide (Gd-DTPA-BMA) in renal 3D-magnetic resonance angiography (MRA): a phase II studyThomas Kittner, Jens Rudolf, Joan Falco Fages, et al.
European Radiology|July 9, 2008
Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trialBernd Tombach, Klaus Bohndorf, Wolfgang Brodtrager, et al.
Pageof 4